Nephron
Case Report
Amlodipine Besylate Induced Acute Interstitial NephritisEjaz A.A.a · Fitzpatrick P.M.a · Haley W.E.a · Wasiluk A.a · Durkin A.J.b · Zachariah P.K.aaDepartment of Hypertension and Nephrology Mayo Clinic Jacksonville, Fla., and bUniversity of South Florida School of Medicine, Tampa, Fla., USA
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: July 28, 2000
Issue release date: August 2000
Number of Print Pages: 3
Number of Figures: 3
Number of Tables: 0
ISSN: 1660-8151 (Print)
eISSN: 2235-3186 (Online)
For additional information: https://www.karger.com/NEF
Abstract
Adverse effects of amlodipine besylate, a widely used antihypertensive medication, include peripheral edema, flushing, headache, pruritus, and rash. An adverse renal effect attributable to the medication has hitherto not been reported in the literature. We herein report a case of amlodipine besylate induced acute interstitial nephritis.
© 2000 S. Karger AG, Basel
Related Articles:
References
-
Nielson EG: Pathogenesis and therapy of interstitial nephritis. Kidney Int 1998;35:1257–1270.
- Murray TG, Goldberg M: Analgesic-associated nephropathy in the USA: Epidemiologic, clinical and pathogenetic features. Kidney Int 1978;13:64–71.
- Cameron JS: Allergic interstitial nephritis: Clinical features and pathogenesis. Q J Med 1988;66:97–115.
-
Brenner BM (ed): The Kidney. Philadelphia, Saunders, 1996.
- Rastegar A, Kashgarian M: The clinical spectrum of tubulointerstitial nephritis. Kidney Int 1998;54:313–327.
- Pusey CD, Saltissi D, Bloodworth L, Rainford DJ, Christie JL: Drug associated acute interstitial nephritis: Clinical and pathological features and the response to high dose steroid therapy. Q J Med 1983;52:194–211.
-
Shallcross H, Padley SP, Glynn MJ, Gibbs DD: Fatal renal and hepatic toxicity after treatment with diltiazem. Br Med J 1987;295:1236–1237.
-
Achenbach V, Rafelt M, Wagner K, Neumayer HH: Acute renal failure due to diltiazem. Lancet 1985;i:176.
Article / Publication Details
Published online: July 28, 2000
Issue release date: August 2000
Number of Print Pages: 3
Number of Figures: 3
Number of Tables: 0
ISSN: 1660-8151 (Print)
eISSN: 2235-3186 (Online)
For additional information: https://www.karger.com/NEF
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
